Last deal

$2M

Amount

Venture - Series Unknown

Stage

21.10.2022

Date

1

all rounds

$2M

Total amount

General

About Company
CASS Pharmaceuticals develops treatments for diabetes, specializing in glucagon formulations and the creation of a bi-hormonal pump.

Industry

Sector :

Subsector :

Also Known As

CASS Pharma

founded date

01.01.2020

Last funding type

Venture - Series Unknown

IPO status

Private

Description

Founded in 2020 and based in Franklin, Tennessee, CASS Pharmaceuticals is a medical company that focuses on providing rapid-acting insulin for diabetic patients. They specialize in developing glucagon formulations and are known for their work in creating a bi-hormonal pump. With a strong emphasis on diabetes treatment, CASS Pharmaceuticals aims to improve the lives of individuals living with diabetes through innovative solutions.
Contacts